Higher Rate of Bladder Neck Incompetence in Mixed Urinary Incontinence
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 1, 2023 -- Patients with mixed urinary incontinence (MUI) have a higher rate of bladder neck incompetence (BNI), according to a study published online Sept. 29 in the World Journal of Urology.
Yu-Chen Chen, from the Kaohsiung Medical University in Taiwan, and colleagues conducted a retrospective analysis involving 184 patients with stress UI (SUI), MUI, urge UI (UUI), or dry overactive bladder (OAB) who underwent transrectal ultrasound between 2017 and 2022. In all included patients, the presence of BNI and urethral incompetence was recorded.
Overall, 91, 84, 76, and 71 percent of patients exhibited BNI in the MUI, SUI, UUI, and OAB dry groups, respectively. Significantly more patients had BNI in the MUI than OAB dry group. The researchers found that compared to those without postoperative OAB symptoms, patients with OAB symptoms after anti-incontinence surgery had significantly higher rates of BNI and urethral incompetence. The rate of postoperative BNI and urethral incompetence was lower for individuals with versus without improved OAB symptoms after surgery among MUI patients with preoperative BNI.
"We demonstrated that the rates of BNI and urethral incompetence were particularly high in the MUI group and that the presence of these anatomical abnormalities was associated with postoperative OAB symptoms," the authors write.
Abstract/Full Text (subscription or payment may be required)
Source: HealthDay
Posted : 2023-11-01 22:52
Read more
- Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- Risk Factors Found for Neurogenic Bladder After Rectal Cancer Surgery
- Kids Still Find It Easy to Buy Flavored Vapes Online
- Can AI Boost Accuracy of Doctors' Diagnoses?
- ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
- Generic Medications Can Keep OOP Costs Down for Neurological Conditions
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions